investigated the mechanism of action of sorafenib in liver fibrosis.[56] They revealed a decrease in total Kcr in a liver fibrosis mouse model, caused by upregulation of the crotonyl erasers HDAC1, HDAC3, and CDYL. Here, CDYL is linked to Hepatic fibrosis.